Kenvue Inc. (NYSE:KVUE) Shares Purchased by Birch Hill Investment Advisors LLC

Birch Hill Investment Advisors LLC lifted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 50.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 167,071 shares of the company's stock after buying an additional 55,766 shares during the period. Birch Hill Investment Advisors LLC's holdings in Kenvue were worth $3,597,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Cornerstone Wealth Group LLC acquired a new stake in shares of Kenvue during the fourth quarter worth $2,731,000. Perigon Wealth Management LLC lifted its stake in shares of Kenvue by 72.2% during the fourth quarter. Perigon Wealth Management LLC now owns 18,615 shares of the company's stock worth $401,000 after buying an additional 7,806 shares during the period. Kanawha Capital Management LLC lifted its position in Kenvue by 7.1% during the fourth quarter. Kanawha Capital Management LLC now owns 171,297 shares of the company's stock valued at $3,688,000 after purchasing an additional 11,401 shares during the period. Cerity Partners LLC lifted its position in Kenvue by 332.7% during the fourth quarter. Cerity Partners LLC now owns 331,021 shares of the company's stock valued at $7,127,000 after purchasing an additional 254,524 shares during the period. Finally, Seelaus Asset Management LLC lifted its position in Kenvue by 55.8% during the fourth quarter. Seelaus Asset Management LLC now owns 36,440 shares of the company's stock valued at $785,000 after purchasing an additional 13,048 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Royal Bank of Canada decreased their target price on shares of Kenvue from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, February 9th. UBS Group upped their price objective on shares of Kenvue from $20.00 to $23.00 and gave the company a "neutral" rating in a research note on Tuesday, December 19th. JPMorgan Chase & Co. dropped their price objective on shares of Kenvue from $25.00 to $24.00 and set an "overweight" rating for the company in a research note on Friday, February 9th. William Blair initiated coverage on shares of Kenvue in a research note on Wednesday, April 3rd. They set a "market perform" rating for the company. Finally, Sanford C. Bernstein initiated coverage on shares of Kenvue in a research note on Thursday. They set an "underperform" rating and a $18.00 price objective for the company. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $24.85.

Kenvue Price Performance

NYSE:KVUE traded down $0.31 on Friday, hitting $19.14. The stock had a trading volume of 9,414,820 shares, compared to its average volume of 16,872,299. The company has a fifty day moving average price of $19.94 and a two-hundred day moving average price of $20.20. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.78 and a current ratio of 1.12. Kenvue Inc. has a 1-year low of $17.82 and a 1-year high of $27.80.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, February 8th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.28 by $0.03. Kenvue had a net margin of 9.87% and a return on equity of 15.62%. The firm had revenue of $3.67 billion for the quarter, compared to analyst estimates of $3.78 billion. Kenvue's quarterly revenue was down 2.7% on a year-over-year basis. As a group, equities research analysts predict that Kenvue Inc. will post 1.17 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 28th. Stockholders of record on Wednesday, February 14th were issued a $0.20 dividend. The ex-dividend date was Tuesday, February 13th. This represents a $0.80 annualized dividend and a dividend yield of 4.18%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.